Complete remission upon bortezomib-dexamethasone therapy in three heavily pretreated multiple myeloma patients relapsing after allogeneic stem cell transplantation.
Tosi
Patrizia
P
Zamagni
Elena
E
Cangini
Delia
D
Tacchetti
Paola
P
Perrone
Giulia
G
Ceccolini
Michela
M
Baccarani
Michele
M
Cavo
Michele
M
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001897:Boronic Acids / Q000008:administration & dosage*; D000069286:Bortezomib; D003907:Dexamethasone / Q000008:administration & dosage*; D005260:Female; D006085:Graft Survival / Q000187:drug effects*; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000517:prevention & control*; D011480:Protease Inhibitors / Q000008:administration & dosage*; D011719:Pyrazines / Q000008:administration & dosage*; D012008:Recurrence; D012074:Remission Induction; D016879:Salvage Therapy; D033581:Stem Cell Transplantation; D013997:Time Factors; D014184:Transplantation, Homologous
D000893:Anti-Inflammatory Agents; D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone